DETROIT—Free to produce generic versions of the product after DoorBlocker’s 20-year patent ran out last month, hundreds of businesses have begun distributing cheap, off-brand doorstops to retail outlets nationwide, industry analysts confirmed Tuesday. “Now that anyone can manufacture a doorstop without fear of legal challenges from the DoorBlocker company, we can expect the market to be flooded with tons of these low-cost knockoffs of the original door-impeding device,” said market researcher Paul Holbloom, naming brands like DoorHalt, SwingLock, PropStop, and Wedge as being among those that have gone on sale in just the past few weeks. “It’s likely DoorBlocker will keep some of its most loyal customers, but I expect that in the future we’ll see many opting for doorstops that are more economical and less of a status symbol.” Holbloom added that the expiration of DoorBlocker’s patent would have no effect on the sizable segment of the market that has always held their doors open with bricks or shoes.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Coronavirus sell-off threatens to end U.S. stock market's decade-long bull runThe Dow Jones, S&P and Nasdaq correction reflects investors re-assessing the potential economic damage caused by the coronavirus.
Les mer »
Spring training roundup: Yankees' Cole sharp in second outingGerrit Cole tossed 2 2/3 shutout innings in his second spring outing to help the...
Les mer »
7 Cheap and Discreet Sex Toys Perfect for CollegeThese sex toys are cheap, discreet, and compact enough to fit under your twin-sized bed.
Les mer »
South Carolina Hands Democrats A Challenge: Running In A Strong Job MarketUnemployment is low — especially in South Carolina — and consumer confidence has been high. And the conventional wisdom is that a strong economy helps buoy incumbent presidents to reelection.
Les mer »
FDA approves generic form of $750 pill DaraprimThe FDA approved the first generic version of Daraprim, which is used to treat an infection caused by a parasite. The drug came to public attention in 2015 after Turing Pharmaceuticals increased its price from $13.50 to $750 per pill.
Les mer »
Greece pushes back migrants on Turkish border 'onslaught'Greek police fired teargas to push back hundreds of migrants gathered on its bor...
Les mer »